ANNA WALKER: Open Payments
NPI 1386154045 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,475 in 33 payments from 8 companies in 2025. Trend: 2023 $697 · 2024 $795 · 2025 $1,475
Food & beverage: $1,475
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $583 |
| ABBVIE INC. | 11 | $454 |
| Janssen Scientific Affairs, LLC | 2 | $177 |
| Madrigal Pharmaceuticals | 1 | $125 |
| Ipsen Biopharmaceuticals, Inc | 1 | $47 |
| Celltrion USA Inc. | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: TREMFYA, RINVOQ, SKYRIZI, REZDIFFRA, IQIRVO, VEGZELMA, XIFAXAN, CREON.
Industry payments across GA — which companies pay providers there.
